CRBU
Price
$1.25
Change
+$0.16 (+14.68%)
Updated
Jun 6, 04:14 PM (EDT)
Capitalization
101.38M
67 days until earnings call
TLSA
Price
$1.41
Change
-$0.00 (-0.00%)
Updated
Jun 6, 04:42 PM (EDT)
Capitalization
164.76M
Interact to see
Advertisement

CRBU vs TLSA

Header iconCRBU vs TLSA Comparison
Open Charts CRBU vs TLSABanner chart's image
Caribou Biosciences
Price$1.25
Change+$0.16 (+14.68%)
Volume$17.75K
Capitalization101.38M
Tiziana Life Sciences
Price$1.41
Change-$0.00 (-0.00%)
Volume$900
Capitalization164.76M
CRBU vs TLSA Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. TLSA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and TLSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CRBU: $1.09 vs. TLSA: $1.41)
Brand notoriety: CRBU and TLSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 43% vs. TLSA: 41%
Market capitalization -- CRBU: $101.38M vs. TLSA: $164.76M
CRBU [@Biotechnology] is valued at $101.38M. TLSA’s [@Biotechnology] market capitalization is $164.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileTLSA’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • TLSA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than TLSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while TLSA’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 4 bearish.
  • TLSA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than TLSA.

Price Growth

CRBU (@Biotechnology) experienced а -6.03% price change this week, while TLSA (@Biotechnology) price change was +2.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

TLSA is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLSA($165M) has a higher market cap than CRBU($101M). TLSA YTD gains are higher at: 102.528 vs. CRBU (-31.447). TLSA has higher annual earnings (EBITDA): -17.14M vs. CRBU (-159.14M). CRBU has more cash in the bank: 208M vs. TLSA (201K). TLSA has less debt than CRBU: TLSA (247K) vs CRBU (26.2M). CRBU has higher revenues than TLSA: CRBU (9.92M) vs TLSA (0).
CRBUTLSACRBU / TLSA
Capitalization101M165M61%
EBITDA-159.14M-17.14M929%
Gain YTD-31.447102.528-31%
P/E RatioN/AN/A-
Revenue9.92M0-
Total Cash208M201K103,483%
Total Debt26.2M247K10,607%
FUNDAMENTALS RATINGS
TLSA: Fundamental Ratings
TLSA
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUTLSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRCHF0.170.03
+17.66%
Brainchip Holdings Ltd.
ECTM0.62N/A
-0.05%
ECA Marcellus Trust I
MTUAY202.57-2.92
-1.42%
MTU Aero Engines AG
LDNXF152.75-3.59
-2.29%
London Stock Exchange Ltd.
WTBDY9.59-0.31
-3.08%
Whitbread Plc

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with FATE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-3.54%
FATE - CRBU
54%
Loosely correlated
-5.63%
CCCC - CRBU
54%
Loosely correlated
-4.87%
CRSP - CRBU
53%
Loosely correlated
+1.37%
AXON - CRBU
50%
Loosely correlated
+1.08%
ABOS - CRBU
50%
Loosely correlated
-0.47%
More

TLSA and

Correlation & Price change

A.I.dvisor tells us that TLSA and ADTX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLSA and ADTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLSA
1D Price
Change %
TLSA100%
-1.40%
ADTX - TLSA
24%
Poorly correlated
-7.69%
SAGE - TLSA
24%
Poorly correlated
+3.44%
AGIO - TLSA
23%
Poorly correlated
-1.32%
DARE - TLSA
22%
Poorly correlated
+5.16%
CRBU - TLSA
22%
Poorly correlated
-3.54%
More